PMC:7283670 / 127185-127349 JSONTXT

{"project":"LitCovid-PD-MONDO","denotations":[{"id":"T691","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"T692","span":{"begin":154,"end":163},"obj":"Disease"}],"attributes":[{"id":"A691","pred":"mondo_id","subj":"T691","obj":"http://purl.obolibrary.org/obo/MONDO_0100096"},{"id":"A692","pred":"mondo_id","subj":"T692","obj":"http://purl.obolibrary.org/obo/MONDO_0005249"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}

{"project":"LitCovid-PD-CLO","denotations":[{"id":"T187","span":{"begin":81,"end":84},"obj":"http://purl.obolibrary.org/obo/CLO_0051582"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}

{"project":"LitCovid-PD-CHEBI","denotations":[{"id":"T283","span":{"begin":18,"end":33},"obj":"Chemical"}],"attributes":[{"id":"A21853","pred":"chebi_id","subj":"T283","obj":"http://purl.obolibrary.org/obo/CHEBI_24261"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}

{"project":"LitCovid-sentences","denotations":[{"id":"T1051","span":{"begin":0,"end":164},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}

{"project":"LitCovid-PD-HP","denotations":[{"id":"T326","span":{"begin":154,"end":163},"obj":"Phenotype"}],"attributes":[{"id":"A326","pred":"hp_id","subj":"T326","obj":"http://purl.obolibrary.org/obo/HP_0002090"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}

{"project":"LitCovid-PubTator","denotations":[{"id":"2635","span":{"begin":113,"end":121},"obj":"Species"},{"id":"2650","span":{"begin":134,"end":142},"obj":"Disease"},{"id":"2651","span":{"begin":154,"end":163},"obj":"Disease"}],"attributes":[{"id":"A2635","pred":"tao:has_database_id","subj":"2635","obj":"Tax:9606"},{"id":"A2650","pred":"tao:has_database_id","subj":"2650","obj":"MESH:C000657245"},{"id":"A2651","pred":"tao:has_database_id","subj":"2651","obj":"MESH:D011014"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"Administration of glucocorticoids in moderate doses is another intervention that has recently been indicated for patients with severe COVID‐19‐associated pneumonia."}